Summaries for patients. The influence of kidney disease on outcomes of patients with heart attack.
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000368:Aged; D000369:Aged, 80 and over; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D001241:Aspirin / Q000627:therapeutic use; D015331:Cohort Studies; D003404:Creatinine / Q000097:blood; D005260:Female; D006493:Heparin / Q000627:therapeutic use; D017052:Hospital Mortality; D006801:Humans; D008297:Male; D009203:Myocardial Infarction / Q000150:complications*; D015425:Myocardial Reperfusion; D011379:Prognosis; D016016:Proportional Hazards Models; D051437:Renal Insufficiency / Q000150:complications* / Q000401:mortality / Q000628:therapy*; D012189:Retrospective Studies; D012307:Risk Factors
D000319:Adrenergic beta-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D006493:Heparin; D003404:Creatinine; D001241:Aspirin